LeonaBio (LONA) Total Current Liabilities (2019 - 2026)
LeonaBio (LONA) posted quarterly Total Current Liabilities of $6.7 million for Q1 2026, up 21.38% year-over-year from $5.5 million in Q1 2025, and down 85.97% quarter-over-quarter from $47.5 million in Q4 2025.
LeonaBio (LONA) Total Current Liabilities (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has reported Total Current Liabilities for 8 consecutive years, with $6.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities rose 21.38% year-over-year to $6.7 million; the TTM figure through Mar 2026 stood at $6.7 million (up 21.38% YoY), while the FY2025 annual figure was $47.5 million, up 261.65% from the prior year.
- Total Current Liabilities eased to $6.7 million in Q1 2026 per LONA's latest filing, from $47.5 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $47.5 million in Q4 2025 and bottomed at $2.8 million in Q3 2025.
- Historically, Total Current Liabilities has averaged $18.2 million across 5 years, with a median of $20.2 million in 2023.
- On a YoY basis, Total Current Liabilities climbed as much as 261.65% in 2025 and fell as far as 89.96% in 2025.
- LeonaBio's Total Current Liabilities stood at $21.4 million in 2022, then jumped by 34.57% to $28.8 million in 2023, then sank by 54.46% to $13.1 million in 2024, then jumped by 261.65% to $47.5 million in 2025, then tumbled by 85.97% to $6.7 million in 2026.
- Business Quant data shows LONA's Total Current Liabilities at $6.7 million in Q1 2026, $47.5 million in Q4 2025, and $2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 630.93 Mn |
| 10 | LeonaBio | 180.91 Mn | 129.85 Mn | - | 7.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.67 Mn |
| Dec 31, 2025 | 47.50 Mn |
| Sep 30, 2025 | 2.79 Mn |
| Jun 30, 2025 | 2.98 Mn |
| Mar 31, 2025 | 5.49 Mn |
| Dec 31, 2024 | 13.14 Mn |
| Sep 30, 2024 | 27.75 Mn |
| Jun 30, 2024 | 26.90 Mn |
| Mar 31, 2024 | 25.60 Mn |
| Dec 31, 2023 | 28.84 Mn |
| Sep 30, 2023 | 28.62 Mn |
| Jun 30, 2023 | 21.66 Mn |
| Mar 31, 2023 | 20.15 Mn |
| Dec 31, 2022 | 21.43 Mn |
| Sep 30, 2022 | 10.26 Mn |
| Jun 30, 2022 | 9.69 Mn |
| Mar 31, 2022 | 9.47 Mn |
| Dec 31, 2021 | 9.29 Mn |
| Sep 30, 2021 | 9.39 Mn |
| Jun 30, 2021 | 7.63 Mn |